ArticleGigaScience2025
SeedGerm-VIG: an open and comprehensive pipeline to quantify seed vigor in wheat and other cereal crops using deep learning-powered dynamic phenotypic analysis.
Article in GigaScience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Bioactivity ofPlants (Basel, Switzerland) · 2026Article
- SeedGerm-VIG: an open and comprehensive pipeline to quantify seed vigor in wheat and other cereal crops using deep learning-powered dynamic phenotypic analysis.GigaScience · 2025Article
- Multispectral imaging and automated analysis for quantifying grain quality to reveal known and potential novel alleles affecting grain traits in wheat.Frontiers in plant science · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
backgroundAs one of the most important cereal crops, wheat (Triticum aestivum L.) production and grain quality are essential to many nations in the world. Early developmental phases such as seed germination and seedling establishment are key to wheat's growth and development as they impact directly on a crop's early performance and yield potential. Hence, it is critical to develop varieties with favorable early growth characteristics under various growing conditions.
resultsHere, we present SeedGerm-VIG, an automated and comprehensive pipeline developed for assessing seed vigor in wheat and other cereal crops. Building on the SeedGerm system, we integrated multiple deep learning models (i.e., YOLOv8x-Germ and optimized U-Net) and computer vision algorithms into the automated seed-level analysis pipeline to identify key germination phases and measure seed-, root-, and seedling-level phenotypic traits. Then, by using a time-series directed graph, we not only tracked root tips to reliably measure root emergence during the germination procedure (seed-lot R2 = 84.1%) but also established a new approach to examine speed and uniformity of seed germination. These resulted in the establishment of a vigor scoring matrix, through which 21 commercial genotypes' (n = 494 randomly sampled seeds, with over 29,500 seed-level images) vigor scores were summarized and evaluated at key phases such as protrusion, radicle emergence, and chloroplast biogenesis. These measures largely matched with manual assessment based on the International Seed Testing Association (ISTA) guidelines. Finally, we also demonstrated that the SeedGerm-VIG pipeline could be used to assess seed vigor for other cereal crops, including rice (n = 120 seeds) and barley (n = 240 seeds), reproducibly.
conclusionsIn conclusion, we believe that our work demonstrates a valuable step forward to enable a broader plant and crop research community to examine seed vigor and vigor-related phenotypic features in an automated manner, facilitating effective and scalable plant selection and relevant seed science research for crop improvement.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.